KRISTI MAHAN: Open Payments
NPI 1033569496 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 25 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $353 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 6 | $158 |
| Merck Sharp & Dohme LLC | 4 | $111 |
| Tempus AI, Inc | 4 | $80 |
| Genmab U.S., Inc. | 4 | $70 |
| Caris MPI, Inc. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $17 |
Products named: Lenvima, LYNPARZA, XT CDX, Tivdak, KEYTRUDA, MI CANCER SEEK, GATTEX, ELAHERE.
Industry payments across PA — which companies pay providers there.
